Inve US ▾
HRHRZN

Horizon Technology Finance (HRZN) Q2 FY26 earnings call: guidance and Q&A

Earnings call· Jun 2026 (Q2 FY26)· Financials· Aug 5, 2026

Source: earnings call transcript

Executive summary

Horizon Technology Finance Q2 FY26 – Merger Integration and Portfolio Growth Amidst Write-Downs

Horizon Technology Finance is actively integrating its merger with Monroe Capital, focusing on enhancing underwriting and origination capabilities to drive sustainable portfolio growth. Despite a significant write-down related to one portfolio company, Soli, the company is expanding its investment pipeline and committed backlog, while also returning capital to shareholders through share repurchases and maintaining distributions, including special distributions, supported by spillover income.

Highlights

5

  • Grew debt investment portfolio for the third consecutive quarter, funding 9 investments totaling $73 million.

  • Ended the quarter with a committed and approved backlog of $228 million, up $48 million from the prior quarter end.

  • Achieved a portfolio yield on debt investments of just under 15% for the second quarter, among the highest in the BDC industry.

  • Repurchased approximately 1.4 million shares of common stock at an average price of $4.54, and authorized an additional $20 million for repurchases.

  • Undistributed spillover income of $0.33 per share as of June 30.

Concerns

4

  • NAV per share decreased by $0.75 to $6.23, primarily due to write-downs of a large investment in Soli.

  • Wrote down entire $20 million equity holding and $19 million debt investment in Soli due to cash burn and fundraising headwinds.

  • Net investment income (excluding one-time merger expenses) of $0.18 per share covered regular distributions but was below the combined regular and special distributions.

  • Loan portfolio yield decreased to 14.9% from 15.8% in Q2 FY25.

Guidance & targets

CategoryTargetConfidence
Regular monthly distributions
$0.06 per share
high materiality
High
Special monthly distributions
$0.03 per share
high materiality
High
Net investment income coverage of distributions
at or above declared distributions
high materiality
Medium
Debt investment portfolio growth
another quarter of growth
medium materiality
High

Deals & partnerships

Monroe Capital Corporation Merger to significantly enhance available capital for investments and kick off a new chapter of growth.

Completed in April, laying the foundation for sustainable and profitable long-term growth.

Risks & headwinds

Significant write-down of investments in Soli Q2 FY26

$20 million equity holding and $19 million debt investment written down.

Mitigation:Focused on recovering as much value as possible from these investments.

Venture capital market bifurcation and muted IPO market for non-AI companies Current

86% of Q2 VC investment in AI; IPO market remains relatively muted for non-AI companies.

Mitigation:Continued disciplined origination and underwriting; significant opportunities remain for venture loan originations in life sciences and tech.

Net investment income not covering combined regular and special distributions Q2 FY26

NII (excl. merger expenses) of $0.18 per share vs. combined regular and special distributions of $0.09 per share (regular $0.06 + special $0.03).

Mitigation:Expectation for growth and predictive pricing strategy to enable NII coverage over time.

What to watch in Q3 FY26

NII coverage of distributions

over time
Current NII (excl. merger expenses) $0.18/share vs. combined distributions $0.09/share
Target NII at or above declared distributions

Why it matters

Demonstrates profitability and sustainability of shareholder returns, crucial for investor confidence.

As we prudently work to deploy the capital from the merger and move towards our target leverage, it remains our goal to deliver NII at or above our declared distributions over time.

Find out whether HRZN delivers this. Inve re-checks your case every morning.

Q&A highlights

Are there broader implications from the Soli write-down for other portfolio companies, and how will the merger impact the size and diversification of future investments?

Management stated the Soli event was company-specific, driven by fundraising headwinds, and they are working to maximize recovery. Regarding pipeline, the merger with Monroe Capital allows for larger bite sizes, playing into growth-stage companies, and increasing portfolio diversification, with the goal of growing the platform and taking larger tickets, potentially co-investing with Monroe.

“Given that we're part of Monroe, we have the ability to partner with them on certain deals and where that makes sense, we will definitely do that. The goal, obviously, is to grow the platform so that we can take larger bite sizes and larger tickets and deals, but also to be able to play into the growth phase and growth stage rather more.”

asked by Melissa Wedel · answered by Paul Seitz

2 min read 6 chapters

Detailed narrative

Merger Integration and Strategic Vision

The merger with Monroe Capital Corporation in April significantly enhanced available capital for investments, marking a new chapter of growth. The company is actively investing in underwriting, credit capabilities, technology, and personnel to build a scalable platform. These investments are aimed at consistently growing the portfolio, steadily increasing Net Investment Income (NII), and ultimately creating additional shareholder value over the long term.

Portfolio Performance and Soli Write-Down

The debt investment portfolio grew for the third consecutive quarter, reaching $677 million. However, Net Asset Value (NAV) per share declined by $0.75 to $6.23, primarily due to significant write-downs related to one portfolio company, Soli. This included a $20 million write-down of an equity holding and a $19 million write-down of a debt investment, following the company's substantial cash burn and fundraising challenges.

Origination and Pipeline Expansion

Horizon funded 9 debt investments totaling $73 million in Q2. The committed and approved backlog increased by $48 million from the prior quarter to $228 million, driven by larger venture loan opportunities. The company anticipates continued debt investment portfolio growth in Q3, supported by a strong pipeline and $87 million in new venture loan transactions already awarded.

Credit Rating Scale Alignment

Effective June 30, the internal credit rating scale was revised from a 4-to-1 system to a 1-to-5 system (where 1 represents the highest credit rating). This change was implemented to align with Monroe Capital's scale, improving consistency and efficiency across the organization, particularly for co-investments.

Under the new scale, 88% of the debt portfolio's fair value was rated 1, 2, or 3, with 12% rated 4 or 5.

Venture Capital Market Dynamics

The venture capital market saw approximately $146 billion invested in Q2, making it the second-highest quarter on record, following Q1's $267 billion. First half 2026 deal value is already 30% above the full year 2025 total, with 86% of the Q2 investment concentrated in large AI deals.

Despite a bifurcated market and muted IPO activity for non-AI companies, management believes significant opportunities for venture loan originations persist in life sciences and tech.

Capital Management and Shareholder Returns

The company repurchased 1.4 million shares of common stock at an average price of $4.54 during the quarter and increased its share repurchase authorization by an additional $20 million. Available liquidity stood at $229 million, comprising $135 million in cash and $94 million in available credit. With a net leverage of 0.65:1, the company has a potential new investment capacity of $459 million.

Summary of the company's earnings call; see how call summaries are prepared. Not investment advice.